Testimonies & Filings

The Biden administration should withdraw its support of S.2710 at least until the NTIA provides evidence of alleged anticompetitive conduct in a failing mobile apps market through its study. Until then, support for the S.2710 is rushed and undermines the effectiveness of the fact-finding exercise carried out by the NTIA via its RFC.

ITIF supports SEC’s efforts to ensure publicly traded companies disclose relevant information on their cybersecurity practices and material cybersecurity incidents, which would enable investors to make more informed decisions, in line with existing SEC disclosure requirements. This type of transparency will not only help investors make more informed decisions, but it should also incentivize companies to adopt cybersecurity best practices.

There’s a battle being fought now for the soul of the global trade and economic system; it’s imperative that like-minded nations collaborate to emerge victorious in it.

Accepting Epic’s arguments and preventing Apple from continuing to operate its closed mobile ecosystem would eliminate a signature attractive feature of Apple’s products, to the detriment of consumer welfare, competition, and innovation.

Facebook’s business justification for limiting platform access for rival app developers was self-evident: It did not want to help them replicate its core functions, nor did it want to share its intellectual property—certainly not for free. That is rational competition, not unlawful anticompetitive behavior.

ITIF applauds both the Biden administration and U.S. Congress for articulating and advancing the Creating Helpful Incentives to Produce Semiconductors (“CHIPS”) for America Act, which has been passed out of the Senate and House in largely similar form in their respective U.S. Innovation and Competition Act (USICA) and America COMEPTES Act.

Responding to a Commerce Department inquiry into the Indo-Pacific Economic Framework (IPEF), ITIF provided recommendations on global data flows, privacy, and governance; innovation and advanced manufacturing; standards-setting for data, cybersecurity, AI, cloud services, and other new and emerging technologies; the potential for an IPEF climate-change agenda; and using IPEF to launch a joint commercial intelligence forum.

Expenditures for retail prescriptions have been roughly stable for the past two decades as a share of total U.S. health-care expenditures. Instead of applying broad price controls, policymakers should promote affordability and mitigate out-of-pocket costs for individuals.

In revising merger guidelines, antitrust agencies should refrain from embracing the populist narrative that pursues market deconcentration and corporate disintegration at the expense of companies’ innovation, efficiency, and competitiveness.

U.S. industry does do not yet have all the necessary technology to decarbonize while maintaining its competitive edge in manufacturing. Only with continued federal and private investment in low-carbon RD&D will the United States be able to achieve the twin goals of supporting a robust manufacturing sector while reducing and ultimately eliminating emissions.